No Association of Proton Pump Inhibitor Use with Fasting or Postload Glycaemia in Patients with Cardiovascular Disease: A Cross-Sectional Retrospective Study

Background: Proton pump inhibitor (PPI) use was reportedly associated with an excess of adverse cardiovascular (CV) events, thus making their systemic effects relevant to public health. PPIs reduce gastric acid secretion, causing increased gastrin release. Gastrin stimulates β-cell neogenesis and en...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Int J Med Sci
Egile Nagusiak: Kruszelnicka, Olga, Kuźma, Marcin, Pena, Iwona Z., Perera, Ian B., Chyrchel, Bernadeta, Wieczorek-Surdacka, Ewa, Surdacki, Andrzej
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Ivyspring International Publisher 2017
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5599926/
https://ncbi.nlm.nih.gov/pubmed/28924374
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijms.19457
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak